We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Commercial Version of Clinical Radiology Workstation Available; PACS and RIS to Follow

By MedImaging International staff writers
Posted on 03 May 2011
A commercial version of clinical radiology workstation software is now available, previously only offered as an open-source application.

ClearCanvas, Inc. (Toronto, Canada), a medical imaging informatics company, announced the commercial release of their clinical radiology ClearCanvas Workstation, Clinical Edition. ClearCanvas open source software has been employed for over five years, with more than 14,000 worldwide users in a number of clinical settings. With such extensive application, commercial versions of the products were an obvious next step.

ClearCanvasradiology information system/picture archiving and communication system (RIS/PACS) recently received US Food and Drug Administration (FDA) 510(k) clearance. This regulatory status allows for commercial distribution of the ClearCanvas software.

ClearCanvas expects to release a commercial version of their PACS software suite in Q2 2011 with the commercial release of their RIS following in Q4 2011. Additional versions of the Workstation are already planned for 2011; product upgrades and technical support are included free of charge during the first license year. ClearCanvas will continue to release new versions of their open source software as well.

"Open source products have always been an integral part of who we are and that will not change," stated Norman Young, company president and founder. "At the same time, we also recognize how important it is to create a vibrant commercial ecosystem by bringing our products to different markets around the world. We are extremely excited to offer what so many of our users have been asking for--a commercial, FDA-cleared version of our very popular Workstation product."

Related Links:

ClearCanvas



Mobile X-Ray System
K4W
Ultrasound Table
Women’s Ultrasound EA Table
Biopsy Software
Affirm® Contrast
X-ray Diagnostic System
FDX Visionary-A

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.